Collaborative multicenter investigation of marrow transplantation for sickle cell disease: Current results and future directions

Biology of Blood and Marrow Transplantation

Volumn 3, Issue 6, 1997, Pages 310-315

  Walters, Mark C ^a,b   Patience, Melinda ^a   Leisenring, Wendy ^a   Rogers, Zora R ^c   Dinndorf, Patricia ^d   Davies, Sally C ^e   Roberts, Irene A G ^e   Yeager, Andrew ^f   Kurtzberg, Joanne ^g   Bunin, Nancy ^h   Scott, J Paul ⁱ   Wall, Donna A ^j   Wayne, Alan S ^k   Wiley, Joseph ^l   Darbyshire, Patrick J ^m   Mentzer, William C ⁿ   Smith, Franklin O ^o   Sullivan, Keith M ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f EMORY UNIVERSITY   (United States)

^g DUKE UNIVERSITY   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^j SAINT LOUIS UNIVERSITY   (United States)

^k UNIVERSITY OF MIAMI   (United States)

^l UNIVERSITY OF NORTH CAROLINA   (United States)

^m BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o INDIANA UNIVERSITY   (United States)

more..

Author keywords

Bone marrow transplantation; Sickle cell disease

Indexed keywords

CYCLOSPORIN; METHOTREXATE;

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL TRIAL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MULTICENTER STUDY; PRESCHOOL CHILD; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; METHOTREXATE; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 0031299076     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Vermylen C, Cornu G, Phillips M, Ninane J, Borja A: Bone marrow transplantation in sickle cell anemia. Arch Dis Child 66:1195, 1991.
2. Ferster A, De Valck C, Azzi N, Fondu P, Toppet M, Sariban E: Bone marrow transplantation for severe sickle cell anaemia. Br J Haematol 80:102, 1992.
3. Johnson FL, Mentzer WC, Kalinyak KA, Sullivan KM, Abboud MR: Bone marrow transplantation for sickle cell disease: the USA experience. Am J Pediatr Hematol Oncol 16:22, 1994.
4. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K, Bernaudin F, Matthews DC, Storb R, Sullivan KM: Bone marrow transplantation for sickle cell disease. N Engl J Med 335:369, 1996.
5. Mentzer WC, Heller S, Pearle PR, Hackney E, Vichinsky E: Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol 16:27, 1994.
6. Walters MC, Patience M, Leisenring W, Eckman JR, Buchanan GR, Rogers ZR, Olivieri NF, Vichinsky E, Davies SC, Mentzer WC, Powars D, Scott JP, Bernaudin F, Ohene-Frempong K, Darbyshire PJ, Wayne A, Roberts IAG, Dinndorf P, Brandalise S, Sanders JE, Matthews DC, Appelbaum FR, Storb R, Sullivan KM: Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2:100, 1996.
7. Kodish E, Lantos J, Stocking C, Singer PA, Siegler M, Johnson FL: Bone marrow transplantation for sickle cell disease: a study of parents' decisions. N Engl J Med 325:1349, 1991.
8. Sullivan KM, Walters MC, Patience M, Leisenring W, Buchanan GR, Castro O, Davies SC, Dickerhoff R, Eckman JR, Graham ML, Ohene-Frempong K, Powars D, Rogers Z, Scott JP, Styles L, Vichinsky E, Wall D, Wayne A, Wiley J, Wingard J, Bunin N, Camitta B, Darbyshire PJ, Dinndorf P, Klingebiel T, McMahon L, Mentzer WC, Olivieri N, Orringer E, Parkman R, Roberts IAG, Sanders JE, Smith F, Storb R: Collaborative study of marrow transplantation for sickle cell disease: aspects specific for transplantation of hemoglobin disorders. Bone Marrow Transplant 19 (Suppl 2):102, 1997.
9. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons, 79, 1980.
10. Slattery JT, Sanders JE, Buckner CD, Schaffer RL, Lambert KW, Langer FP, Anasetti C, Bensinger WI, Fisher LD, Appelbaum FR: Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant 16:31, 1995.
11. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons, 168, 1980.
12. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P, Leisenring W, Shulman H: Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89:3048, 1997.
13. Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD, Ildstad ST: Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J Immunol 156:380, 1996.
14. Walters MC, Sullivan KM, Bernaudin F, Souillet G, Vannier JP, Johnson FL, Lenarsky C, Powars D, Bunin N, Ohene-Frempong K, Wall D, Plouvier ME, Bodigoni P, Lutz P, Sanders JE, Matthews DC, Patience M, Appelbaum FR, Storb R: Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 85:879, 1995.
15. Kalinyak KA, Morris C, Ball WS, Ris MD, Harris R, Rucknagel D: Bone marrow transplantation in a young child with sickle cell anemia. Am J Hematol 48:256, 1995.
16. Ferster A, Christophe C, Dan B, Devalck C, Sariban E: Neurologic complications after bone marrow transplantation for sickle cell anemia. Blood 86:408, 1995. [letter]
17. Abboud MR, Jackson SM, Barredo J, Holden KR, Cure J, Laver J: Neurologic complications following bone marrow transplantation for sickle cell disease. Bone Marrow Transplant 17:405, 1996.
18. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Dhooge C, Sariban E: Sickle cell disease and haematopoietic stem cell transplantation in Belgium. Bone Marrow Transplant 19 (Suppl 2):99, 1997.
19. Wingard JR, Plotnick LP, Freemer CS, Zahurak M, Piantadosi S, Miller DF, Vriesendorp HM, Yeager AM, Santos GW: Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 79:1068, 1992.
20. Giorgiani G, Bozzola M, Locatelli F, Picco P, Zecca M, Cisternino M, Dallorso S, Bonetti F, Dini G, Borrone C: Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marow transplantation and results of treatment with recombinant human growth hormone. Blood 86:825, 1995.
21. Huma Z, Boulad F, Black P, Heller G, Sklar C: Growth in children after bone marrow transplantation for acute leukemia. Blood 86:819, 1995.
22. Platt OS, Rosenstock W, Espeland MA: Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 311:7, 1984.
23. De Sanctis V, Galimberti M, Lucarelli G, Polchi P, Ruggiero L, Vullo C: Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child 66:517, 1991.
24. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR: Pregnancies following high dose cyclophosphamide with or without high dose busulfan or total body irradiation and bone marrow transplantation. Blood 87:3045, 1996.
25. Issaragrisil S, Visuthisakchai S, Suvatte V, Tanphaichitr VS, Chandanayingyong D, Schreiner T, Kanokpongsakdi S, Siritanaratkul N, Piankijagum A: Brief report: transplantation of cord blood stem cells into a patient with severe thalassemia. N Engl J Med 332:367, 1995.
26. Brichard B, Vermylen C, Ninane J, Cornu G: Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr 128:241, 1996.
27. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335:157, 1996.
28. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli R, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte J-P, Fernandez M, Chastang C: Outcome of cord-blood transplantation from related and unrelated donors. New Engl J Med 337:373, 1997.
29. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993.
30. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease: life expectance and risk factors for early death. N Engl J Med 330:1639, 1994.
31. Lucarelli G, Giardini C, Baronciani D: Bone marrow transplantation in thalassemia. Semin Hematol 32:297, 1995.
32. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, Andreani M, Agostinelli F, Albertini F, Clift RA: Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 329:840, 1993.
33. Piomelli S: Sickle cell diseases in the 1990s: the need for active and preventive intervention. Semin Hematol 28:227, 1991.
34. Davies SC: Bone marrow transplant for sickle cell disease-the dilemma. Blood Rev 7:4, 1993.
35. Platt OS, Guinan EC: Bone marrow transplantation in sickle cell anemia: the dilemma of choice. N Engl J Med 335:426, 1996. [editorial]
36. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR: Effect of Hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317, 1995.
37. Scott JP, Hillery CA, Brown ER, Misiewicz V, Labotka RJ: Hydroxyurea therapy in children severely affected with sickle cell disease. J Pediatr 128:820, 1996.
38. Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Devalck C, Fondu P, Toppet M, Sariban E: Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 88:1960, 1996.
39. Styles LA, Vichinsky E: Effects of a long-term transfusion regimen on sickle cell-related illnesses. J Pediatr 125:909, 1994.
40. Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, Olivieri N, Vichinsky E, Wang W, Brambilla D: Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 126:896, 1995.
41. Adams RJ, Brambilla D, McKie VC, Files B, Vichindky E, Abboud M, Hsu L, Pegelow C, Woods G, Miller S, Wang W, Olivieri N, Berman B, Hurlet AJ, Criscoll C, Scher C, Wright W, Gallagher D, Carl EM, Nichols PT, Kutler A, Zimmerman R: Stroke prevention in sickle cell disease (STOP): baseline characteristics of trial patients. Blood 90 (Suppl 1):123a, 1997. [abstract]
42. Ferster A, Bujan W, Corazza F, Devalck C, Fondu P, Toppet M, Verhas M, Sariban E: Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood 81:1102, 1993.